Data as of Aug 19
| +0.13 / +0.45%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 38.50, with a high estimate of 40.00 and a low estimate of 37.00. The median estimate represents a +31.26% increase from the last price of 29.33.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.